Epigenetic silencing of human T (brachyury homologue) gene in non-small-cell lung cancer

Biochemical and Biophysical Research Communications

Volumn 365, Issue 2, 2008, Pages 221-226

  Park, Jong Chul ^a   Chae, Young Kwang ^a   Son, Choon Hee ^c   Kim, Myoung Sook ^a   Lee, Juna ^a,b   Ostrow, Kimberly ^a   Sidransky, David ^a   Hoque, Mohammad Obaidul ^a   Moon, Chulso ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Dong A University   (South Korea)

Author keywords

Brachyury homologue (mouse); Lung adenocarcinoma; Non small cell lung cancer; Promoter hypermethylation; T gene; Tumor suppressor gene

Indexed keywords

AMINOMETHYLTRANSFERASE; BISULFITE; CELLULAR RETINOIC ACID BINDING PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; NOEY2 PROTEIN; RETINOIC ACID BINDING PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; EPIGENETICS; GENE EXPRESSION PROFILING; GENE SILENCING; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LUNG TUMOR; METHYLATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE; UPREGULATION;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; EPIGENESIS, GENETIC; FETAL PROTEINS; GENE SILENCING; GENE TARGETING; GENE THERAPY; HUMANS; T-BOX DOMAIN PROTEINS;

EID: 36248939277     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.10.144     Document Type: Article

References (17)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55 (2005) 74-108
2. Herman J.G., and Baylin S.B. Promoter-region hypermethylation and gene silencing in human cancer. Curr. Top. Microbiol. Immunol. 249 (2000) 35-54
3. Jones P.A., and Laird P.W. Cancer epigenetics comes of age. Nat. Genet. 21 (1999) 163-167
4. Merlo A., Herman J.G., Mao L., Lee D.J., Gabrielson E., Burger P.C., Baylin S.B., and Sidransky D. CpG island methylation is associated with transcriptional silencing of the tumour suppressor. Nat. Med. 1 (1995) 686-692
5. Li B., Goyal J., Dhar S., Dimri G., Evron E., Sukumar S., Wazer D.E., and Band V. CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression. Cancer Res. 61 (2001) 8014-8021
6. Sato K., Tomizawa Y., Iijima H., Saito R., Ishizuka T., Nakajima T., and Mori M. Epigenetic inactivation of the RUNX3 gene in lung cancer. Oncol. Rep. 15 (2006) 129-135
7. Tang X., Khuri F.R., Lee J.J., Kemp B.L., Liu D., Hong W.K., and Mao L. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. J. Natl. Cancer Inst. 92 (2000) 1511-1516
8. Suzuki H., Gabrielson E., Chen W., Anbazhagan R., van Engeland M., Weijenberg M.P., Herman J.G., and Baylin S.B. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat. Genet. 31 (2002) 141-149
9. Yamashita K., Upadhyay S., Osada M., Hoque M.O., Xiao Y., Mori M., Sato F., Meltzer S.J., and Sidransky D. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2 (2002) 485-495
10. Li J., Zhang Z., Dai A.P., Popkie C.M., Plass C., Morrison C., Wang Y., and You M. RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancer. Neoplasia 5 (2003) 362-366
11. Olopade O.I., and Wei M. FANCF methylation contributes to chemoselectivity in ovarian cancer. Cancer Cell 3 (2003) 417-420
12. Kispert A., Koschorz B., and Herrmann B.G. The T protein encoded by Brachyury is a tissue-specific transcription factor. EMBO J. 14 (1995) 4763-4772
13. Wilson V., Manson L., Skarnes W.C., and Beddington R.S. The T gene is necessary for normal mesodermal morphogenetic cell movements during gastrulation. Development 121 (1995) 877-886
14. Wilson V., and Beddington R.S. Expression of T protein in the primitive streak is necessary and sufficient for posterior mesoderm movement and somite differentiation. Dev. Biol. 192 (1997) 45-58
15. Vujovic S., Henderson S., Presneau N., Odell E., Jacques T.S., Tirabosco R., Boshoff C., and Flanagan A.M. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J. Pathol. 209 (2006) 157-165
16. Edwards Y.H., Putt W., Lekoape K.M., Stott D., Fox M., Hopkinson D.A., and Sowden J. The human homolog T of the mouse T (Brachyury) gene; gene structure, cDNA sequence, and assignment to chromosome 6q27. Genome Res. 6 (1996) 226-233
17. Lingbeek M.E., Jacobs J.J., and van Lohuizen M. The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator. J. Biol. Chem. 277 (2002) 26120-26127